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Introduction
People with substance abuse disorders show an attentional bias towards drug cues (conditioned stimuli, CSs), and such cues acquire strong motivational control over behavior (Thewissen et al., 2007; Field et al., 2008; Franklin et al., 2011) . Individual variation in the propensity to attribute motivational value (incentive salience) to reward cues can be studied in animals using a Pavlovian Conditioned Approach (PCA) procedure. Some rats, "sign-trackers" (STs) are attracted to reward cues to a much greater extent than others ("goal-trackers", GTs), which instead direct their responding toward the location of reward delivery Robinson et al., 2014) . In addition, reward cues function as more effective conditioned reinforcers and are more effective in instigating reward-seeking behavior Yager et al., 2015) in STs than GTs. Importantly, these different behavioral responses to food-associated cues predict the extent to which drug cues come to motivate approach and drug-seeking behavior Yager et al., 2015) . Dopamine (DA) neurotransmission, especially in the core of the nucleus accumbens (NAc), is known to be important in conferring motivational properties to reward cues (Robinson & Berridge, 1993; Cardinal et al., 2002) . In both humans and nonhuman animals, food-or drug-related stimuli evoke DA release in the NAc (Boileau et al., 2007; Day et al., 2007; Flagel et al., 2011; Fotros et al., 2013) , and, reward cues are more effective in evoking DA release in the NAc core in STs than GTs (Flagel et al., 2011) .
Although differential rates of spontaneous DA release events have been documented in selectively bred lines of rats that either sign-or goal-track (Flagel et al., 2010) , this has not been described in outbred STs and GTs. However, both systemic and intraaccumbens injections of DA antagonists disrupt ST conditioned responses (CRs) to a greater extent than GT CRs (Danna & Elmer, 2010; Flagel et al., 2011; Saunders et al., 2013; Yager et al., 2015) , and enhancing DA release increases sign-tracking, but not goal-tracking, behavior (Danna et al., 2013) .
Amphetamine (AMPH) also augments the motivational value of CSs (Taylor & Robbins, 1984; Kelley & Delfs, 1991; Fletcher et al., 1998; Wyvell & Berridge, 2000; Peciña & Berridge, 2013) . Interestingly, AMPH given directly into the NAc core selectively reinstates cue-induced drug seeking in STs (Saunders et al., 2013) . AMPH is thought to exert effects on motivated behavior primarily by increasing DA release, in part due to reversal of the DA transporter (DAT; Giros et al., 1996) . It is possible, therefore, that differential levels of DAT expression and/or function contribute to the greater effect of AMPH in STs compared to GTs (Saunders et al., 2013) . Thus, we sought to characterize the expression and function of the DAT in rats that vary in their propensity to attribute incentive salience to reward cues.
Materials & Methods

Subjects & Pavlovian Training
Outbred male Sprague-Dawley rats (n=99; from both Harlan & Charles River Laboratories) were either housed individually (Exp. 3) or housed in pairs (Exp. 1-2) in a temperature-and humidity-controlled vivarium with a reverse light cycle. Food and water were available ad libitum. Starting 1-week after arrival, all procedures were performed during the dark phase of the light cycle.
Pavlovian training used operant chambers and procedures described previously . Briefly, conditioning (5 days) consisted of 25 CS-US pairings/day on a variable time 90s schedule. Each CS presentation (extension and illumination of a lever) lasted for 8s. Retraction of the lever was followed immediately by delivery of 1 banana-flavored pellet (US) into the food cup. The degree to which rats displayed lever (ST) or food cup (GT) directed behavior was quantified using a PCA index, as described previously (Meyer et al., 2012; . Factors included in the index consisted of (1) response probability [P(lever) -P(food cup)], (2) response bias [(lever deflections -food cup entries) / (lever deflections + food cup entries)], and (3) the latency [(lever deflection latency -food cup entry latency) / 8] for making either a lever-directed or food cup-directed CR during the CS. The PCA index was calculated from the average of their Day 4 and Day 5 data according to the following formula:
[(probability difference + response bias + latency score) / 3]. Based on this index, STs were defined as animals that had a score ranging from +0.4 to 1.0. In contrast, GTs had a score ranging from -1.0 to -0.4. Although rats with Intermediate scores (INs) were classified (PCA score -0.4 to +0.4), they were not used in the present experiments because we wanted to concentrate on differential neurochemistry between rats that varied markedly in their propensity to attribute incentive salience to the lever-CS (i.e., STs vs GTs). All procedures were conducted according to a protocol approved by the University of Michigan Committee on Use and Care of Animals (UCUCA).
Experiment 1: Presynaptic Regulation of DA Signaling in the NAc core
Stimulated DA Release in Brain Slices
A subset of rats (ST, n=6; GT, n=5) were left undisturbed in their home cages for ~2-5 weeks after PCA training, and were subsequently used for ex vivo measurement of stimulated DA release using fast-scan cyclic voltammetry (FSCV). ST and GT rats were sacrificed via rapid decapitation and brains were immediately extracted. 400µm-thick coronal slices of brain tissue were collected and bathed in oxygenated artificial cerebral spinal fluid (aCSF) at 32°C. During FSCV, a glass-encased carbon fiber microelectrode was lowered into the NAc core. Calibration of the carbon fiber FSCV electrode allows for current measurements to be converted to DA concentration ([DA]; 1.9-5.5 nA/µM DA). A bipolar stimulating electrode was placed nearby and positioned to evoke optimal DA release. Following stabilization, alternating 1-pulse (300µA, 4ms) and 5-pulse (300µA, 20Hz) electrical stimulations were delivered to the slice, once every 5-minutes. Since both stimulations resulted in similar DA responses, and because the kinetics of 1-pulse stimulations may be more accurately modeled using MichaelisMenten parameters, only the 1-pulse stimulation data are presented in the results.
Current changes recorded on the electrode are shown and plotted against the applied voltage (Eapp) and time. The holding potential applied to the carbon-fiber electrode (-0.4 V) was ramped to +1.3 V and back to -0.4 V at a rate of 10 Hz.
Following stimulation, the peak [DA] represents the total amount of DA released into the extracellular space ([DA]c). This measurement, calculated at the peak [DA] following stimulation, may be impacted by differences in both DA release and uptake (Wightman et al., 1988; Wu et al., 2001; Ramsson, Howard, et al., 2011) , and therefore was modeled using Michaelis-Menten parameters, with the help of Demon Voltammetry software provided courtesy of Dr. Sara R. Jones at Wake Forest University (Yorgason et al., 2011) . DA uptake was quantified using Vmax and the apparent Km. Vmax, the maximum speed of DA uptake ([DA] per second), is associated with DAT surface expression and turnover. Km is inversely related to the affinity for DA to bind DAT. As has been described elsewhere (Wu et al., 2001; Calipari et al., 2015) , at baseline Km was set to 160 nM and Vmax was calculated as a value of DA uptake. In order to determine the amount of DA released per single stimulation pulse ([DA]p), the amount of DA removed by uptake (calculated using Vmax and Km values) was subtracted from [DA]c following stimulation, using Demon Voltammetry.
Tissue DA Content
Ventral striatal dopamine content was analyzed 3 weeks after cessation of conditioning. STs and GTs (n=6/group) were sacrificed via rapid decapitation. Brains were removed quickly and the ventral striatum was dissected on ice. Synaptosomes were then prepared and dopamine content was analyzed as described previously (Johnson et al., 2005; Chen et al., 2009) . Briefly, bilateral tissue from single rats were first homogenized in 0.32 M sucrose containing 1 mM EDTA and Complete Mini protease inhibitor cocktail (Roche, Basel, Switzerland). Homogenates were then centrifuged at 4 °C (800 × g, 10 min) to remove cellular debris. The supernatant was next centrifuged again (12,000 × g, 15 min, 4 °C) and the pellet was used as crude synaptosomes. The pellet containing crude synaptosomes was resuspended in 100 µl of oxygenated KrebRinger's Buffer (KRB) (145 mM NaCl, 2.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.0 mM MgCl 2 , 10 mM glucose, 24.9 mM NaHCO 3 , 0.05 mM ascorbic acid, 0.05 mM pargyline, pH 7.4).
Synaptosomes (10 µl) were lysed using an internal standard solution composed of in KRB. Dopamine content in each sample was measured using high-performance liquid chromatography (HPLC) with electrochemical detection.
DAT Expression
After having been left undisturbed in their home cages for 3-5 weeks, rats [ST (n=30) and GT (n=22)] were rapidly decapitated and brains were harvested for measurement of DAT surface expression in synaptosomes. On ice, bilateral ventral striatal tissue (including the NAc core and shell) was obtained through hand-dissection.
Due to low levels of DAT expression in the ventral striatum, each sample contained tissue pooled from 2-4 rats with similar PCA scores (ST, 10 samples; GT, 8 samples). On average, the difference between the strongest and weakest ST/GT in each pooled sample was a PCA index of 0.11 ± 0.046.
Synaptosome preparation was conducted as described above. Synaptosomal membrane proteins were subsequently biotinylated with 2 mg/ml sulfo-NHS-SS-biotin (Thermo Scientific, Waltham, MA, USA) in PBS/Ca-Mg (1 mM CaCl2 and MgCl2) overnight at 4 °C. Afterward, the biotinylation reaction was quenched by adding 100 mM glycine and incubating for 15 min. Synaptosomes were then washed twice with 100 mM glycine in PBS/Ca-Mg and subsequently lysed in RIPAE buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X 100 and Complete Mini Protease inhibitor; Roche, Basel, Switzerland) for 1 hr at 4 °C. The obtained lysate was cleared by centrifugation at 20,000 g for 20 min at 4 °C and measured for protein concentration using a Bio-Rad Dc protein assay kit (Hercules, CA, USA). Samples (1 mg) were incubated with monomeric avidin beads (50 µl) overnight at 4 °C. The next day the beads were washed three times with RIPAE buffer and eluted in 2 X Laemmli sample buffer. The eluates and 50 µg of total synaptosomal lysate were resolved by SDS-PAGE (10% Tris-glycine) and immunoblotted using anti-DAT antibody (mouse monoclonal; A bipolar stimulating electrode (AP, -5.2; ML, ±0.8 mm relative to bregma; Plastics One, Roanoke, VA) was lowered into the ventral tegmental area (VTA) until electricallyevoked DA release was able to be measured in the striatum, as previously described (Vander Weele et al., 2014) . DA release was recorded using glass-encased cylindrical carbon-fiber electrodes. FSCV relied on the oxidation and reduction of the analyte of interest (i.e. DA) in response to the application of a triangular waveform (oxidative scan, -0.4 to 1.3 V; reductive scan, 1.3 V to -0.4 V; 400V/s). This waveform was cycled for 20 min at 60 Hz, followed by another 20 min at 10 Hz.
After the bipolar stimulating electrode was lowered into the VTA and cemented in place, stimulations of the VTA (60 Hz, 40 pulse) were applied once every 10 minutes until a stable DA response in the NAc core was achieved. Rats then received a saline injection (1 ml/kg, IP) followed by an AMPH injection (5 mg/kg, IP) 40 minutes later.
VTA stimulations continued throughout this period, and finished 40 minutes after the final post-drug stimulation. At that time, rats were sacrificed via sodium pentobarbital overdose (60 mg/kg, IP) and electrolytic lesions (tungsten electrodes, 20 µA for 15 s) of the recording site were made. Brains were then removed and sliced to confirm NAc core electrode placements. Data were recorded for 40 minutes after AMPH administration in order to mirror the amount of time of a single conditioning session.
Analysis of stimulated DA release and uptake was performed using Demon Voltammetry software, in a similar fashion to Experiment 1. Vmax (the speed of DA uptake), Km (the ability of the treatment to inhibit DA uptake), and [DA]p (the ability of a single stimulation to evoke DA release) were first analyzed following the saline injection. The Vmax value determined for each rat following saline was then held constant when analyzing post-AMPH data, allowing for drug-induced changes in both Km and [DA]p to be modeled Daberkow et al., 2013; Calipari et al., 2015) . "Fixing" Vmax at pre-drug levels is used because, as a competitive inhibitor of DA uptake at DATs, AMPH does not alter Vmax (Jones et al., 1999; Schmitz et al., 2001; John & Jones, 2007; Ferris et al., 2015) . Although AMPH has been reported to alter surface DAT in vitro (Zahniser & Sorkin, 2009 ), a recent study found that administration of AMPH in vivo or to striatal slices did not change DAT distribution (Block et al., 2015) . Due to individual variation in the DA responses following both saline and AMPH, calculations of Km, [DA]p, and [DA]c were analyzed as a percent change from saline measurements.
Experiment 3: Behavioral Response to AMPH
A subset of ST/GT rats underwent stereotaxic surgery for implantation of chronic 22 gauge bilateral guide cannulae (Plastics One) aimed at the NAc core (A/P, +1.8; M/L, ±1.6; D/V, -5; mm from bregma and skull), as described previously (Saunders et al., 2013; Singer et al., 2014) . After 1-week recovery from surgery, rats underwent 2 additional days of PCA training to confirm that conditioned responding was consistent with presurgical behavior.
The experiment assessed the effect of bilateral (2, 10, or 20µg; Wyvell and Berridge, 2000) microinjections of AMPH into the NAc core on PCA. On the first testing day all rats received saline (vehicle) microinjections. Thereafter, once every third day rats received an AMPH microinjection. The order in which doses were administered was counterbalanced across rats. After microinjection, rats were returned to their home cages for 15 minutes before being transported to operant chambers for PCA assessment.
Rats then completed 25 conditioning trials using identical procedures as during initial PCA training. Rats were left undisturbed on days between microinjections. At the conclusion of experiment rats were deeply anaesthetized (sodium pentobarbital; 60 mg/kg, IP), brains were removed, and coronal brain sections were obtained to verify cannula tip placements. Only rats with bilateral cannula tips placed correctly in the NAc core were included in the behavioral analyses.
Statistical Analyses
For initial Pavlovian training, independent t-tests were used to analyze the number of food cup contacts during inter-stimulus-intervals in ST and GT rats. 
Results
Pavlovian Training
As described previously (Flagel et al., 2007; Robinson et al., 2014) , patterns of conditioned responding were measured in order to identify sub-populations of rats.
Over the course of 5 training days, STs increasingly made contact with the lever CS, whereas GTs failed to engage in this behavior ( Figure 1A ; STs, PCA index +1.0 to +0.4, 38% of rats trained; GTs, PCA index -0.4 to -1.0, 36% of rats trained). Rather, GTs showed increased food cup contacts (i.e., the CR characteristic of this sub-population)
while STs showed decreases in this behavior ( Figure 1B) . Additionally, similar to a previous report (Meyer et al., 2012) , GTs tended to contact the food cup more during inter-stimulus-intervals than STs (t97=1.868, p=0.0765). Although "intermediate" rats
were classified (neither ST nor GT, PCA score -0.4 to +0.4), they were not used in the present experiments because we wanted to compare rats that differed maximally in their propensity to attribute incentive salience to reward cues; i.e., STs and GTs. A key factor that contributes to [DA]c levels following stimulation is DA uptake (Wightman et al., 1988; Wu et al., 2001; Ramsson, Howard, et al., 2011) . Therefore, the speed of DA uptake (Vmax) in STs and GTs was investigated ( Figure 2H ). Relative to GTs, STs displayed faster clearance of extracellular DA in the NAc core (t9=2.616, *p=0.0280). Together, these findings suggest that, compared to STs, greater stimulated
[DA]c in GTs ( Figure 2E ) results from relatively slow DA uptake, and not from differences in their ability to release DA ([DA]p). In other words, faster DA uptake in STs restricts the ability of electrical stimulation to increase [DA]c.
Increased speed of DA uptake in STs may reflect greater DAT expression compared to GTs. This was examined by measuring DAT expression in synaptosomes prepared from ventral striatal tissue. Indeed, we found that STs had greater surface expression of DATs than GTs (t16=2.718, *p=0.0152; Figure 3A) , although, there was no difference between STs and GTs in total DAT expression in synaptosomal lysates (t16=1.386, p=0.1848, ns; Figure 3B ). Thus, greater DAT surface expression in STs may account for greater DA uptake in STs following ex vivo stimulation of terminals. Figure 4C) show that, 30 minutes after AMPH administration, there was greater inhibition of DA uptake in STs than GTs compared to baseline (saline) conditions. Differences in DA uptake following AMPH, relative to saline, were determined from apparent Km values calculated using Michaelis-Menten modeling. Increases in Km values after AMPH represent enhanced inhibition of DA uptake. As expected, systemic AMPH injection reduced DA uptake in both STs and GTs ( Figure 4D ; time effect F4,44=19.43, ***p=0.0001). However, AMPH produced greater inhibition of DA uptake in STs than in GTs (group effect, F1,11=6.55, *p=0.0266; group x time interaction, F4,44=3.81, **p=0.0097). Bonferroni tests revealed that this reduction in uptake in STs progressed over time, reaching significant difference from GTs by 30 minutes post-injection. These data suggest that greater DAT surface expression in STs than in GTs may facilitate the ability of AMPH to inhibit DA uptake in STs.
In addition to reducing DA uptake, AMPH also increases synaptic DA levels by promoting vesicular release and efflux through DATs. As measured at the peak [DA] in the NAc core following VTA stimulation, AMPH enhanced the ability of stimulation to increase extracellular DA levels in both ST and GT rats ([DA]c time effect, F4,44=5.52, **p=0.0011; data not shown). Since changes in peak [DA]c may reflect both DA release and uptake (Wightman et al., 1988; Wu et al., 2001; Ramsson, Howard, et al., 2011) in the synapse following stimulation, an effect that is exaggerated by AMPH to a greater degree in STs than in GTs. In addition, while NAc core DA responses measured using FSCV following electrical stimulation of the VTA allow for detection of differences in vesicular release, and for quantifying differences in reuptake, this technique may not be suitable for determining differences in DA efflux resulting from the depletion of vesicular stores and reversal of DATs produced by AMPH (Ramsson, Howard, et al., 2011) . Furthermore, AMPH may enhance DA release through mechanisms that do not involve DATs (Dela Peña et al., 2015) . Alternatively, the lack of a ST/GT difference in [DA]c and [DA]p may indicate a "ceiling effect". This dose of AMPH would produce an extremely large and non-physiological increase in [DA] (Camp et al., 1994) , and the combination of stimulation parameters and AMPH dose may result in a maximal amount of DA being released. Indeed, STs and GTs have similar synaptosomal DA levels in the ventral striatum ( Figure 2G ), as well as ability to release DA in the NAc core ( Figure 2F ).
Experiment 3: Behavioral Response to AMPH
Given the ability of AMPH to reduce DA uptake to a greater degree in STs than in GTs, we next wanted to determine if this might have a functional consequence at the behavioral level. Thus, we examined the effect of an injection of AMPH into the NAc core on 'contacts' with either the lever (STs) or food cup (GTs) during performance on the PCA task. As expected, control infusions (saline) into the NAc core had no impact on the number of contacts made ( Figure 5A ). However, AMPH produced a dosedependent increase in lever contacts made by STs. This robust increase was detected using a 2-way repeated measures ANOVA (group effect, F1,9=27.82, ***p=0.0005; treatment effect, F3,27=3.14, *p=0.0416; treatment X group interaction, F3,27=3.48, GTs (*p<0.01-0.05, Bonferroni tests). To better understand this change and demonstrate how conditioned responding compared to vehicle, STs and GTs were analyzed separately using 1-way ANOVAs. Indeed, AMPH microinjections significantly increased lever contacts in STs (F3,20=4.615, *p=0.0130) at both 10 and 20 µg doses of AMPH (*p<0.05, Bonferroni tests). In contrast, AMPH did not affect the number of food cup contacts made by GTs (one-way ANOVA, F3,16=1.117, p=0.3713, ns). Finally, AMPH had no effect of food cup contacts in STs (one-way ANOVA, F3,20=2.373, p=0.1007, ns) or lever presses in GTs (one-way ANOVA, F3,16=0.5294, p=0.6685, ns) during the CS period.
Therefore, the effect of AMPH was not to increase sign-tracking in every rat, but only in rats that already attributed incentive salience to the cue (STs). While we hypothesize this may be due to the ability of AMPH to inhibit DA uptake in the NAc core to a greater degree in STs than in GTs, this interpretation may be complicated by the different routes of drug administration (IP vs intra-NAc).
STs may have engaged with the lever more because AMPH enhanced nonspecific motor output to a greater degree in STs (Fletcher et al., 1998) . If this were the case one might expect an increase in food cup contacts during inter-stimulus-intervals.
However, AMPH had no effect on food cup contacts during inter-stimulus-intervals in either STs or GTs (treatment effect, F3,27=0.08, p=0.9723, ns; group effect, F1,9=2.12, p=0.1795, ns; group X treatment interaction, F3,27=0.93, p=0.4408, ns; data expressed as % control; data not shown). We hypothesize, therefore, that increased lever contacts in STs reflects the ability of AMPH to amplify the incentive properties of the CS (Wyvell & Berridge, 2000) , and it appears to do so preferentially in rats that already attribute incentive salience to the CS (STs).
Discussion
There is considerable individual variation in the extent to which predictive reward cues are attributed with incentive salience, in both humans and non-human animals (Mahler & de Wit, 2010; Robinson et al., 2014; Garofalo & di Pellegrino, 2015) .
For some rats (STs) discrete reward cues elicit approach into close proximity with them, and they work avidly to get them. In contrast, other rats (GTs) attribute less incentive value to discrete CSs, approaching the location of reward delivery instead of the CS itself, and they work less avidly for them. Previous studies have shown that DA transmission in the NAc core is more important for both the acquisition (Flagel et al., 2011) and performance of ST than GT CRs. Here we further extend our understanding of how variation in the dopaminergic system may contribute to variation in the motivational control over behavior by reward cues.
Microinfusion of AMPH into the NAc core of STs increased the vigor with which they interacted with the lever-CS, without influencing conditioned behavior in GTs.
This difference may be related to variation in the effect of AMPH on DA neurotransmission, as AMPH produced greater inhibition of DA uptake in STs than in GTs. In addition, STs had greater DAT surface expression in ventral striatal synaptosomes than GTs. In summary, the present results further support the idea that variation in DA neurotransmission may contribute to variation in the propensity to attribute incentive salience to reward cues (Flagel et al., 2011; Robinson et al., 2014) , and in particular, STs and GTs vary in the expression and function of the DAT in the ventral striatum.
Behavioral Response to AMPH
Several studies have shown that inhibiting DA signaling by using DA antagonists, given either systemically (Danna and Elmer, 2010) or just in the NAc core Yager et al., 2015) , decreases sign-tracking, but not goaltracking. Conversely, a lesion of the habenula, which is thought to disinhibit VTA DA neurons and lead to greater DA neurotransmission, enhances sign-tracking, but not goal-tracking (Danna et al., 2013) . Infusion of psychostimulants directly into the NAc increases [DA]c (Heidbreder & Feldon, 1998) , conditioned motivation (Wyvell & Berridge, 2000; Peciña & Berridge, 2013) , and conditioned reinforcement (Fletcher et al., 1998) . In STs, AMPH injected into the NAc core facilitates discrete cue-evoked drug seeking (Saunders et al., 2013) . Consistent with this, the present results provide the first evidence that an AMPH injection into the NAc core is sufficient to facilitate signtracking (but not goal-tracking), presumably because of its ability to preferentially inhibit DA uptake in STs.
DA Signaling
The ex vivo FSCV results indicated greater clearance of DA in STs compared to GTs, potentially a reflection of increased DAT surface expression in STs. It is possible that in STs greater control over DA overflow could allow for more precise time-locked DA release events during CS presentation, influencing lever approach (Flagel et al., 2011) . Indeed, the temporal precision of DA signaling may be very important to the encoding of information regarding salient stimuli (Wieland et al., 2015) . Furthermore, low doses of AMPH may enhance CS-evoked [DA]c (Daberkow et al., 2013) and AMPH can increase [DA]c through inhibition of DAT alone (Siciliano et al., 2014) . While the dose of AMPH used may have been too high to detect ST/GT differences in [DA]c (Camp et al., 1994) , AMPH also did not produce differential effects on stimulated release ([DA]p). We therefore hypothesize that, under more physiological conditions, enhanced inhibition of DA uptake in STs (Km) following AMPH may allow the CS to elevate [DA]c to a greater degree than in GTs, enhancing conditioned approach.
In contrast, slower DA uptake in GTs is consistent with results from DAT knockdown (KD) or knock-out mice (Giros et al., 1996; Zhuang et al., 2001) . Interestingly, both GTs (Meyer et al., 2012) and DAT KD mice (Yin et al., 2006) show increased food cup contacts during inter-stimulus-intervals. Thus, relative to STs, lower DAT surface expression in GTs may degrade the temporal control CSs exert over behavior. It is possible that reduced DAT expression may help elevate "tonic" levels of ventral striatal DA in GTs, potentially enhancing the probability of them entering the food cup during inter-stimulus-intervals. Alternatively, lower DAT surface expression in GTs may support different forms of conditioned responding compared to STs. For example, unlike STs who attribute incentive value to discrete CS, GTs are more motivated by contextual CSs . It is possible that lower DAT expression in GTs results in greater "tonic" DA levels in the NAc compared to STs, and this different modality of DA signaling may more readily support contextual conditioning. Instead, the greater peak evoked [DA]c seen in slices may reflect reduced availability of (i.e. saturated) DAT binding in GTs (Wightman et al., 1988; Wu et al., 2001; Garris et al., 2003; Ramsson, Howard, et al., 2011) . Of course there are other modulators of DA transmission that could contribute and require investigation (Garris et al., 2003; Zhang et al., 2009; Melchior et al., 2015) .
DAT Expression
Greater surface DAT in STs may provide more binding sites for AMPH, potentially leading to exaggerated DA responses . It is hypothesized that this drug-induced reduction in DA uptake contributes to the increase in sign-tracking behavior observed. Furthermore, AMPH microinjected into the NAc core also increases conditioned motivation to a greater degree in STs than in GTs (Saunders et al., 2013) . Thus, greater DAT surface expression in STs may facilitate the ability of AMPH to enhance the incentive value of CSs.
Given that STs and GTs have similar total DAT levels, it is possible that these rats differ in the ability to traffic and retain DAT on the synaptic membrane. Increased DAT surface expression could reflect differential activation of proteins that regulate DAT trafficking, including PKCβ (Chen et al., 2009 ). In addition, STs and GTs could also differ in movement of DAT into and out of the membrane after administration of AMPH (Johnson et al., 2005; Yamamoto et al., 2013) . However, a single AMPH injection does not alter the maximal rate of DA uptake (Vmax, a measure of DAT expression) within 1 hour of administration . It remains to be explored whether psychostimulant exposure differently alters DAT expression in STs and GTs.
One caveat to the interpretation of the present findings is that it is not possible to tell if ST/GT differences in DAT expression and function are constitutive, as we hypothesize, or are a result of the initial training experience used to identify the phenotypes. DAT measures were obtained at different time-points weeks after training in an attempt to decrease any recent learning effects. Furthermore, it seems unlikely any such memories would be represented by a change in DAT, especially since in humans constitutive upregulation of DAT due to genetics also influences attraction to cues (Erblich et al., 2005; van Dyck et al., 2005) . Even if DAT surface expression is not elevated before conditioning in STs, it is still likely that their neurophysiology supports up-regulation. Future experiments using micro positron emission tomography imaging of DAT expression in rats before conditioning may address this question.
Conclusion
Tight regulation over DA signaling in the NAc by DATs may facilitate the attribution of incentive salience to the reward-paired CS. Compared to GTs, upregulation of DAT surface expression and function in STs may enhance the ability of AMPH to increase DA signaling in the NAc and amplify sign-tracking. AMPH had no effect on conditioned approach in GTs, and thus presumably did not enhance the incentive value of the lever-CS in GTs. Importantly, individual variation in DAT expression may also produce differences in attraction to reward paired cues in humans.
People with a variable number of tandem repeat (VNTR) polymorphism in the DAT gene (SLC6A3; 9-repeat allele) show greater cue-induced cigarette cravings than noncarriers (Vandenbergh et al., 1992; Erblich et al., 2005; Wetherill et al., 2014) . These individuals show enhanced ventral striatal activation to nicotine cues (Franklin et al., 2009 (Franklin et al., , 2011 and elevated smoking-induced DA signaling in the NAc (Brody et al., 2006) . Furthermore, healthy adults with this polymorphism show greater striatal DAT expression compared to other individuals (Jacobsen et al., 2000; van Dyck et al., 2005; van de Giessen et al., 2009 ; but see the following references, Heinz et al., 2000; Martinez et al., 2001; Lynch et al., 2003) . Therefore, both ST rats and people with the 9-repeat SLC6A3 polymorphism exhibit greater DAT expression and attraction to reward-paired cues relative to GTs and non-carriers, respectively. These findings thus support translational research using variation in Pavlovian conditioned approach behavior to investigate how DAT function contributes to addiction. 
